Drug:
Reaction: VISUAL IMPAIRMENT
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26927333 |
EU |
39 | 2 |
Retinal vein occlusion, Visual impairment, |
||||
| 102 | 26927502 |
US |
83 | 2 |
Visual impairment, |
||||
INSULIN GLARGINE, |
||||
| 103 | 26927623 |
ZA |
2 | |
Visual impairment, Retinal thickening, Optical coherence tomography abnormal, |
||||
FARICIMAB, |
||||
| 104 | 26927672 |
ZA |
2 | |
Off label use, Optical coherence tomography abnormal, Retinal thickening, Visual impairment, |
||||
FARICIMAB, BEVACIZUMAB, |
||||
| 105 | 26927707 |
US |
67 | 2 |
Hunger, Visual impairment, Palpitations, Dry mouth, Heart rate increased, Injection site pain, Injection site pruritus, Injection site swelling, Injection site erythema, Injection site urticaria, Injection site rash, Fatigue, Injection site mass, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 106 | 26927708 |
US |
70 | 2 |
Visual impairment, Oesophageal food impaction, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 107 | 26927962 |
US |
1 | |
Visual impairment, |
||||
DUPILUMAB, |
||||
| 108 | 26928383 |
US |
37 | 1 |
Rash pruritic, Rash macular, Visual impairment, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 109 | 26928426 |
EU |
45 | 2 |
Visual impairment, Macular fibrosis, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, |
||||
| 110 | 26928677 |
US |
2 | |
Nausea, Visual impairment, Headache, Burning sensation, Diarrhoea, Vomiting, Lethargy, |
||||
BIMEKIZUMAB, |
||||
| 111 | 26928836 |
EU |
43 | 2 |
Visual impairment, Gastrointestinal disorder, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, OXAZEPAM, PRAMIPEXOLE, |
||||
| 112 | 26929155 |
ZA |
1 | |
Retinal thickening, Visual impairment, |
||||
FARICIMAB, BEVACIZUMAB, |
||||
| 113 | 26929407 |
51 | 2 | |
Visual impairment, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 114 | 26929495 |
ZA |
67 | 2 |
Optical coherence tomography abnormal, Visual impairment, Retinal thickening, |
||||
FARICIMAB, BEVACIZUMAB, AFLIBERCEPT, |
||||
| 115 | 26929679 |
EU |
73 | 2 |
Syncope, Hypoacusis, Visual impairment, Tooth extraction, Fall, Back pain, Ear discomfort, Skin exfoliation, Periodontitis, |
||||
SITAGLIPTIN, |
||||
| 116 | 26930199 |
US |
67 | 2 |
Visual impairment, Palpitations, Optic nerve injury, Eye pain, Headache, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 117 | 26930591 |
US |
2 | |
Visual impairment, |
||||
BRENSOCATIB, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FERROUS SULFATE, LATANOPROST, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PREDNISOLONE ACETATE, TIMOLOL, ALBUTEROL SULFATE, ATROPINE SULFATE, ATROPINE SULFATE MONOHYDRATE, ATROPINE SULFATE INJECTION, |
||||
| 118 | 26930717 |
EU |
70 | 1 |
Cataract operation, Visual impairment, Blood glucose increased, Visual acuity reduced, |
||||
POMALIDOMIDE, BORTEZOMIB, BELANTAMAB MAFODOTIN, |
||||
| 119 | 26930719 |
US |
||
Visual impairment, |
||||
BRENSOCATIB, |
||||
| 120 | 26930764 |
IR |
28 | 2 |
Ulcerative keratitis, Off label use, Photophobia, Eye pain, Visual impairment, Keratitis, Corneal thinning, Blindness, Atrophy of globe, Hypotony of eye, Corneal perforation, Corneal graft rejection, Ciliary body degeneration, Hypopyon, |
||||
MILTEFOSINE, VORICONAZOLE, VORICONAZOLE INJECTION, VORICONAZOLE, VORICONAZOLE INJECTION, CHLORHEXIDINE GLUCONATE, |
||||
| 121 | 26930779 |
US |
79 | 1 |
Lacrimation increased, Visual impairment, Wrong patient received product, |
||||
MEPOLIZUMAB, ACOLTREMON, ATORVASTATIN CALCIUM, SULFASALAZINE, |
||||
| 122 | 26930893 |
EU |
43 | 2 |
Gastrointestinal disorder, Visual impairment, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, PRAMIPEXOLE, PRAMIPEXOLE, PRAMIPEXOLE, PRAMIPEXOLE, |
||||
| 123 | 26936721 |
74 | 2 | |
Skin lesion, Pain of skin, Pruritus, Visual impairment, Cerebrovascular accident, Contusion, Depression, Suicidal ideation, Fall, Therapy cessation, |
||||
ENCORAFENIB, |
||||
| 124 | 26937169 |
44 | 2 | |
Dry eye, Vision blurred, Vision blurred, Diplopia, Swelling, Visual impairment, |
||||
SUZETRIGINE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, GABAPENTIN, MELOXICAM, DOXYLAMINE SUCCINATE, |
||||
| 125 | 26921405 |
GB |
2 | |
Visual impairment, Headache, Illness, |
||||
| 126 | 26921523 |
US |
78 | 2 |
Visual impairment, Off label use, Product storage issue, |
||||
INSULIN GLARGINE, |
||||
| 127 | 26921549 |
US |
||
Visual impairment, Drug ineffective, Blood glucose increased, Device malfunction, |
||||
INSULIN ASPART, |
||||
| 128 | 26921598 |
US |
1 | |
Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 129 | 26922020 |
US |
66 | 2 |
Visual impairment, Product label issue, |
||||
ORAL SEMAGLUTIDE, |
||||
| 130 | 26922060 |
US |
2 | |
Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 131 | 26922078 |
CA |
60 | 1 |
Asthma, Cough, Disease recurrence, Drug dependence, Dyspnoea, Eosinophil count increased, Eosinophilic granulomatosis with polyangiitis, Full blood count abnormal, Gastrooesophageal reflux disease, Haemoptysis, Hypoaesthesia, Malaise, Neuropathy peripheral, Paraesthesia, Productive cough, Therapeutic product effect incomplete, Upper respiratory tract infection, Vasculitis, Visual impairment, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, RANIBIZUMAB, RANIBIZUMAB, MOMETASONE, MOMETASONE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 132 | 26922116 |
BR |
2 | |
Suicide attempt, Suicidal ideation, Asthenia, Pain, Feeling abnormal, Headache, Wound, Asphyxia, Neoplasm, Tumour pain, Apathy, Swelling, Renal impairment, Cardiac arrest, Eye disorder, Cardiac arrest, Coronavirus infection, Neoplasm malignant, Cardiomegaly, Pancreatic enlargement, Abnormal organ growth, Metastatic carcinoid tumour, Throat cancer, Metastasis, Metastasis, Disease recurrence, Metastases to bone, Diabetes mellitus, Bone pain, Bone marrow infiltration, Malaise, Cataract, Acromegaly, Lung disorder, Syncope, Pruritus, Pneumonia, Arrhythmia, Bone disorder, Visual impairment, Nervousness, Agitation, Feeding disorder, Mass, Panic reaction, Fear, Stress, Skin hypertrophy, Skin discolouration, Balance disorder, Hepatomegaly, Crying, Mood altered, Endocrine disorder, Deformity, Dyskinesia, Fall, Foot deformity, Dysphonia, Needle issue, Productive cough, Coating in mouth, Coating in mouth, Hormone level abnormal, Pancreatic disorder, Tongue disorder, Cardiac disorder, Gallbladder disorder, Liver disorder, Bacteroides test positive, Head injury, Malaise, Retching, Laziness, Skin discolouration, Malaise, Gait disturbance, Haemangioma of bone, Yellow skin, Cardiac valve disease, Gait disturbance, Decreased immune responsiveness, Sluggishness, General physical condition abnormal, Cyanosis, Neuralgia, Oropharyngeal pain, Dyspnoea, Pyrexia, Platelet count decreased, Vomiting, Muscular weakness, Decreased appetite, Headache, Asthenia, Headache, Insomnia, Influenza like illness, Anxiety, Dyspnoea, Fatigue, Back pain, Injection site pain, Therapeutic product effect delayed, Incorrect dose administered, Product quality issue, Product storage error, Inappropriate schedule of product administration, Product physical issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, SERTRALINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 133 | 26922231 |
EU |
43 | 2 |
Gastrointestinal disorder, Visual impairment, |
||||
ORAL SEMAGLUTIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OXAZEPAM, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, PRAMIPEXOLE, |
||||
| 134 | 26922567 |
US |
72 | 2 |
Migraine, Weight loss poor, Visual impairment, Drug ineffective, |
||||
| 135 | 26922679 |
CA |
56 | |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Condition aggravated, Delirium, Diabetes mellitus, Diarrhoea, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Fatigue, Fibromyalgia, Gait disturbance, Glossodynia, Grip strength decreased, Hand deformity, Liver injury, Mobility decreased, Muscular weakness, Nausea, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Arthropathy, Psoriatic arthropathy, Rheumatoid arthritis, Seronegative arthritis, Swelling, Synovitis, Type 2 diabetes mellitus, Weight decreased, Wheezing, Oedema, Hypersensitivity, Rash, Systemic lupus erythematosus, Urticaria, Visual impairment, Vomiting, Weight increased, Upper respiratory tract infection, Wound infection, Treatment failure, Therapeutic product effect decreased, Maternal exposure during pregnancy, Underdose, Product use issue, Prescribed underdose, Product use in unapproved indication, Prescribed overdose, Off label use, Contraindicated product administered, Drug ineffective, Drug tolerance decreased, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, CALCIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, |
||||
| 136 | 26922763 |
EU |
70 | 1 |
Cataract operation, Blood glucose increased, Visual impairment, Visual acuity reduced, |
||||
POMALIDOMIDE, BORTEZOMIB, BELANTAMAB MAFODOTIN, BELANTAMAB MAFODOTIN, |
||||
| 137 | 26922844 |
ZA |
54 | 2 |
Off label use, Optical coherence tomography abnormal, Visual impairment, Retinal thickening, Off label use, Off label use, Retinal thickening, |
||||
FARICIMAB, BEVACIZUMAB, |
||||
| 138 | 26922885 |
GB |
88 | 2 |
Visual impairment, Asthenia, Dizziness, Hypersensitivity, |
||||
FLUCONAZOLE, OXYCODONE HYDROCHLORIDE, OXYCODONE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FLURANDRENOLIDE, BISOPROLOL FUMARATE, ESTRIOL0.2%, ESTRIOL, |
||||
| 139 | 26923006 |
CA |
43 | 2 |
Arthralgia, Synovitis, Back injury, Dislocation of vertebra, Breast cancer stage II, Wound, Feeling hot, Infusion related reaction, Osteoporosis, Frequent bowel movements, Peripheral venous disease, Taste disorder, Memory impairment, Folliculitis, Muscle spasms, Musculoskeletal pain, Decreased appetite, Joint range of motion decreased, Depression, Dry mouth, Lung disorder, Migraine, Exostosis, Abdominal discomfort, Blepharospasm, Headache, Blister, Peripheral swelling, Asthenia, Irritable bowel syndrome, Lupus vulgaris, Night sweats, Pericarditis, Paraesthesia, Abdominal pain upper, Bursitis, C-reactive protein increased, Breast cancer stage III, Anti-cyclic citrullinated peptide antibody positive, Visual impairment, Exposure during pregnancy, Contraindicated product administered, General physical health deterioration, Blood cholesterol increased, Inflammation, Hypocholesterolaemia, Glossodynia, Product quality issue, Vomiting, Live birth, Psoriatic arthropathy, Maternal exposure during pregnancy, Weight increased, Impaired healing, Retinitis, Rash, Pain, Dizziness, Pyrexia, Diarrhoea, Gastrooesophageal reflux disease, Hepatic enzyme increased, Joint swelling, Red blood cell sedimentation rate increased, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, APREMILAST, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, MINOCYCLINE HYDROCHLORIDE, OXYCODONE, OXYCODONE, FLUTICASONE PROPIONATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, PANTOPRAZOLE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, ERENUMAB-AOOE, BOTULINUM TOXIN TYPE A, NAPROXEN, NAPROXEN SODIUM, PHENYLEPHRINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, CANDESARTAN, CANDESARTAN, RANITIDINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, SECUKINUMAB, TRAMADOL HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, PREDNISONE, ABATACEPT, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CYCLOBENZAPRINE, HYDROMORPHONE HYDROCHLORIDE, RAMIPRIL, MEPOLIZUMAB, TOFACITINIB, TOFACITINIB CITRATE, BUPRENORPHINE HYDROCHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PYRIDOXINE HYDROCHLORIDE, INFLIXIMAB, MIRABEGRON, INFLIXIMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, BETAMETHASONE DIPROPIONATE, ERGOCALCIFEROL, APREMILAST, APREMILAST, TRETINOIN, MAGNESIUM CHLORIDE, MAGNESIUM CHLORIDE, VITAMIN C, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RISEDRONATE SODIUM, LISINOPRIL, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, QUETIAPINE FUMARATE, QUETIAPINE, FISH OIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, |
||||
| 140 | 26923117 |
CA |
55 | 1 |
Eye haemorrhage, Visual impairment, Cataract, |
||||
FARICIMAB, |
||||
| 141 | 26923181 |
BR |
2 | |
Drug intolerance, Immunodeficiency, Epistaxis, Loss of consciousness, Haemangioma rupture, Liver injury, Spinal cord disorder, Spinal cord injury, Metastases to spine, Metastases to bone, Metastasis, Metastases to bone, Metastases to liver, Immunodeficiency, Face injury, Skin exfoliation, Dry throat, Alopecia, Erythema, Dry skin, Vulvovaginal dryness, Vulvovaginal discomfort, Vulvovaginal burning sensation, Nasal dryness, Skin disorder, Pruritus, Neoplasm, Gait disturbance, Tumour marker increased, Reflux gastritis, Discouragement, Visual impairment, Greater trochanteric pain syndrome, Feeding disorder, Haemangioma, Disease progression, Weight decreased, Illness, Aphthous ulcer, Oral herpes, Swelling of eyelid, Sinusitis, Rhinitis, Rhinitis allergic, Eyelid sensory disorder, Vein disorder, Frostbite, Ocular hyperaemia, Haemorrhoids, Hair texture abnormal, Trichorrhexis, Eyelid ptosis, Rectocele, Gastrointestinal disorder, Hiatus hernia, Nasal pruritus, Dry eye, Head discomfort, PIK3CA-activated mutation, Swelling, Abdominal discomfort, Head injury, Nasal injury, Skin lesion, Wound, Injury, Oestrogen deficiency, Drug ineffective, Panic disorder, Nasal discomfort, Haematoma, Asthenopia, Hypermetropia, Astigmatism, Petechiae, Dyspnoea, Skeletal injury, Phlebitis, Oral pain, Nasal disorder, Eye swelling, Anosmia, Movement disorder, Pain, Vulvovaginal exfoliation, Chills, Paraesthesia, White blood cell count decreased, Neutrophil count decreased, Pyrexia, Fatigue, Constipation, Dry mouth, Application site bruise, Application site pain, Ear disorder, Urinary tract infection, Skin atrophy, Lip dry, Pain, Pain in extremity, Bone pain, Dysstasia, Application site swelling, Arthralgia, Insomnia, Malaise, Product availability issue, |
||||
FULVESTRANT, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ERGOCALCIFEROL, ACONITUM NAPELLUS, BRYONIA ALBA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS, KALI BICHROMICUM, KALI LODATUM, ZINCUM GLUCONICUM., DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ACONITUM NAPELLUS, ALLIUM CEPA, GELSEMIUM SEMP., ZINCUM GLUCONICUM, BAPTISIA TINCTORIA, ECHINACEA ANGUSTIFOLIA, EUPATORIUM PERFOLIATUM, LOMATIUM DISSECTUM, PUERARIA LOBATA, TRIFOLIUM PRATENSE, PHYTOLACCA DECANDRA, ALLIUM CEPA, ARSENICUM IODATUM, BARYTA CARBONICA, BROMIUM, CALCAREA CARBONICA, KALI MURIATICUM, LACHESIS MUTUS, MERCURIUS SOLUBILIS, SILICEA, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, |
||||
| 142 | 26923496 |
ZA |
2 | |
Optical coherence tomography abnormal, Visual impairment, Off label use, Retinal thickening, |
||||
FARICIMAB, FARICIMAB, AFLIBERCEPT, |
||||
| 143 | 26923569 |
EU |
43 | 2 |
Gastrointestinal disorder, Visual impairment, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ORAL SEMAGLUTIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, OXAZEPAM, PRAMIPEXOLE, |
||||
| 144 | 26923646 |
US |
55 | 2 |
Migraine, Visual impairment, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 145 | 26923748 |
US |
43 | 2 |
Visual impairment, Arthralgia, |
||||
DUPILUMAB, |
||||
| 146 | 26924246 |
42 | 2 | |
Vision blurred, Myopia, Visual impairment, Medication error, Blood iron decreased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 147 | 26924295 |
US |
44 | 1 |
Visual impairment, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 148 | 26924332 |
1 | ||
Asthenopia, Visual impairment, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 149 | 26924676 |
US |
||
Visual impairment, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 150 | 26924748 |
BR |
2 | |
Myocardial infarction, Asthenia, Visual impairment, Limb discomfort, Constipation, Balance disorder, Dry mouth, Foaming at mouth, Hypoaesthesia oral, Lip swelling, Chapped lips, Feeling cold, Hypoaesthesia, Paraesthesia oral, Tremor, Eye disorder, Panic disorder, Swelling, Ill-defined disorder, |
||||
CLADRIBINE, CLADRIBINE, |
||||
| 151 | 26924764 |
US |
76 | 1 |
Blood glucose increased, Visual impairment, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 152 | 26924935 |
CA |
2 | |
Pancreatitis, Pruritus, Intentional product use issue, Drug tolerance decreased, Lower limb fracture, Joint dislocation, Hypoaesthesia, Therapeutic product effect decreased, Treatment failure, Dyspepsia, Swollen joint count increased, Foot deformity, Ear infection, Mobility decreased, Visual impairment, Sciatica, Porphyria acute, Injury, Colitis ulcerative, Osteoporosis, Contraindicated product administered, Incorrect route of product administration, Hypersensitivity, Bronchitis, Facet joint syndrome, Infection, Spondylitis, Drug-induced liver injury, Maternal exposure during pregnancy, Product quality issue, Seronegative arthritis, C-reactive protein, Nasopharyngitis, Migraine, Rheumatic fever, Therapy non-responder, Malaise, Retinitis, Prescribed overdose, Road traffic accident, Drug ineffective, Frequent bowel movements, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, QUETIAPINE FUMARATE, QUETIAPINE, APREMILAST, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, CANDESARTAN, CANDESARTAN, CANDESARTAN, OXYCODONE, TRAMADOL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROMORPHONE HYDROCHLORIDE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, PHENYLEPHRINE HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ERENUMAB-AOOE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, PREDNISONE, PREDNISONE, BETAMETHASONE DIPROPIONATE, CELECOXIB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LANSOPRAZOLE, LANSOPRAZOLE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MESALAMINE, MINOCYCLINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, GOLIMUMAB, VITAMIN C, ERGOCALCIFEROL, SARILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ETANERCEPT, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, LORAZEPAM, CAFFEINE CITRATE, ICOSAPENT ETHYL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, RISEDRONATE SODIUM, SULFASALAZINE, |
||||
| 153 | 26924987 |
US |
1 | |
Glaucoma, Visual impairment, |
||||
TRAMETINIB, TRAMETINIB, TRAMETINIB, DABRAFENIB, DABRAFENIB, DABRAFENIB, |
||||
| 154 | 26925106 |
EU |
1 | |
Visual impairment, |
||||
TIRZEPATIDE, |
||||
| 155 | 26925108 |
US |
38 | 1 |
Blindness, Visual impairment, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 156 | 26925539 |
US |
2 | |
Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 157 | 26925712 |
69 | ||
Neuropathy peripheral, Visual impairment, |
||||
LENVATINIB, |
||||
| 158 | 26925787 |
US |
66 | 2 |
Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 159 | 26925815 |
US |
2 | |
Influenza, Visual impairment, |
||||
TIRZEPATIDE, |
||||
| 160 | 26926212 |
US |
65 | 2 |
Visual impairment, |
||||
FREMANEZUMAB-VFRM, |
||||
| 161 | 26926229 |
US |
1 | |
Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 162 | 26914831 |
US |
31 | 1 |
Chest pain, Visual impairment, Mobility decreased, Muscular weakness, |
||||
DUPILUMAB, |
||||
| 163 | 26915102 |
US |
64 | 2 |
Nausea, Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 164 | 26915119 |
BR |
2 | |
Epistaxis, Neoplasm malignant, Metastases to bone, Breast cancer, Loss of consciousness, Haemangioma, Spinal cord neoplasm, Skull fracture, Spinal cord injury, Metastasis, Metastases to central nervous system, Immunodeficiency, Brain neoplasm, Metastases to liver, Nasal dryness, Skin exfoliation, Skin fissures, Dry skin, Skin atrophy, Tumour marker abnormal, Tumour marker increased, Pain, Discomfort, Hiatus hernia, Reflux gastritis, Discouragement, Visual impairment, Movement disorder, Greater trochanteric pain syndrome, Feeding disorder, Hernia, Burning sensation, Pain of skin, Abdominal discomfort, Malaise, Hepatic lesion, White blood cell count decreased, Neutrophil count decreased, Rhinitis allergic, Sinusitis, Bowel movement irregularity, PIK3CA-activated mutation, Vein disorder, Ill-defined disorder, Pruritus, Lip dry, Erythema, Hair texture abnormal, Swelling, Atrophic vulvovaginitis, Vulvovaginal burning sensation, Vulvovaginal discomfort, Vulvovaginal dryness, Urinary tract infection, Inadequate lubrication, Device physical property issue, Clavicle fracture, Panic disorder, Oestrogen deficiency, Injury, Pain, Alopecia, Skin laceration, Haematoma, Macule, Central nervous system lesion, Vaginal disorder, Haemorrhoids, Spinal disorder, Angiopathy, Neoplasm, Haemangioma of bone, Carpal tunnel syndrome, Head discomfort, Weight decreased, Insomnia, Drug intolerance, Drug ineffective, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, EXEMESTANE, EXEMESTANE, CLONAZEPAM, FULVESTRANT, |
||||
| 165 | 26915171 |
US |
2 | |
Visual impairment, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 166 | 26915186 |
ZA |
86 | 2 |
Visual impairment, Headache, Vitreous floaters, Iridocyclitis, Off label use, Retinal thickening, |
||||
FARICIMAB, |
||||
| 167 | 26915209 |
ZA |
1 | |
Retinal thickening, Visual impairment, |
||||
FARICIMAB, FARICIMAB, AFLIBERCEPT, BEVACIZUMAB, |
||||
| 168 | 26915293 |
CA |
59 | 2 |
Duodenal ulcer perforation, Product use in unapproved indication, Type 2 diabetes mellitus, Maternal exposure during pregnancy, Pericarditis, Therapeutic product effect decreased, Treatment failure, Diarrhoea, Adverse event, Oedema peripheral, Drug ineffective, Psoriatic arthropathy, Nasopharyngitis, Pain in extremity, Hand deformity, Rheumatic fever, Malaise, Retinitis, Systemic lupus erythematosus, Fibromyalgia, Anxiety, Lupus vulgaris, Blister, Asthma, Glossodynia, Anti-cyclic citrullinated peptide antibody positive, Discomfort, Arthralgia, Hypertension, Bronchitis, Liver injury, Hypercholesterolaemia, Pemphigus, Red blood cell sedimentation rate increased, Wound, Contraindicated product administered, Helicobacter infection, Visual impairment, Musculoskeletal stiffness, Intentional product use issue, Off label use, Hypoaesthesia, Alopecia, Adverse drug reaction, Rash, Mobility decreased, Rheumatoid factor positive, Drug intolerance, Fatigue, Rheumatoid arthritis, Hypersensitivity, Blood cholesterol increased, Hepatic enzyme increased, Headache, Decreased appetite, General physical health deterioration, Joint swelling, Abdominal discomfort, Therapeutic product effect incomplete, Infusion related reaction, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ERGOCALCIFEROL, USTEKINUMAB, USTEKINUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, ERGOCALCIFEROL, AZATHIOPRINE, HYDROCORTISONE, HYDROCORTISONE, PREDNISONE, PREDNISONE, PHENYLEPHRINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, MORPHINE SULFATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, LANSOPRAZOLE, LANSOPRAZOLE, RAMIPRIL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, MINOCYCLINE HYDROCHLORIDE, SARILUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, CALCIUM GLUCONATE, CALCIUM GLUCONATE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, APREMILAST, APREMILAST, DESOXIMETASONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, CERTOLIZUMAB PEGOL, MINOCYCLINE, MINOCYCLINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TELMISARTAN, ABATACEPT, ABATACEPT, ABATACEPT, VITAMIN C, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BUPROPION, LISINOPRIL, LORAZEPAM, LORAZEPAM, ACETAMINOPHEN AND CODEINE, CAFFEINE CITRATE, BUPROPION HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROMORPHONE HYDROCHLORIDE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 169 | 26915299 |
US |
2 | |
Visual impairment, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 170 | 26915379 |
US |
53 | |
Visual impairment, |
||||
INSULIN LISPRO, |
||||
| 171 | 26915477 |
US |
65 | |
Visual impairment, |
||||
INSULIN DEGLUDEC, |
||||
| 172 | 26915570 |
US |
54 | 2 |
Visual impairment, Drug ineffective, Unevaluable event, Hunger, Device malfunction, |
||||
| 173 | 26915574 |
US |
58 | |
Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 174 | 26915643 |
US |
2 | |
Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 175 | 26915644 |
US |
1 | |
Visual impairment, Product packaging quantity issue, |
||||
INSULIN ASPART, |
||||
| 176 | 26915719 |
BR |
2 | |
Vulvovaginal injury, Spinal fracture, Vein rupture, Metastases to bone, Metastases to spine, Metastases to liver, Metastasis, Haemorrhage, Hydronephrosis, Urinary retention, Seizure, Breast cancer, Malignant neoplasm progression, Nail cuticle fissure, Epistaxis, Dry skin, Dry mouth, Constipation, Vulvovaginal dryness, Drug ineffective, Petechiae, Skin tightness, Visual impairment, Skin fissures, Skin atrophy, Dry throat, Nasal mucosal disorder, Rhinalgia, Secretion discharge, Insomnia, Throat irritation, Hair texture abnormal, Skin exfoliation, Breast disorder, Tumour marker increased, Calcification metastatic, Weight increased, Flatulence, Reflux gastritis, Hiatus hernia, Gastritis, Muscle spasms, Vitamin B12 deficiency, Feeding disorder, Balance disorder, Head injury, Fall, Dermal absorption impaired, Thermal burn, Nasal congestion, Eye swelling, Phlebitis, Rhinitis allergic, Allergic sinusitis, Decreased immune responsiveness, Gastric polyps, Skeletal injury, Pelvic bone injury, Epistaxis, Oropharyngeal discomfort, Hypersensitivity, Discomfort, Quality of life decreased, Rectocele, Bone lesion, Product distribution issue, Thinking abnormal, Feeling abnormal, Carbohydrate antigen 15-3 increased, PIK3CA-activated mutation, Quality of life decreased, Feeding disorder, Sensory disturbance, Skin discolouration, COVID-19, Bone pain, Condition aggravated, Anosmia, Malaise, Gene mutation, Urinary tract infection, Oral pain, Muscle injury, Hepatic mass, Dysbiosis, Oral disorder, Speech disorder, Chills, Lip swelling, Gait disturbance, Gastrointestinal disorder, Pain, Depressed mood, Myalgia, Atrophic vulvovaginitis, Nasal disorder, Head injury, Malaise, Tumour marker abnormal, Central nervous system lesion, Hepatic lesion, Cervix disorder, Uterine leiomyoma, Bacteriuria, Swelling face, Pruritus, Erythema, White blood cell count decreased, Nausea, Peripheral swelling, Vomiting, Diarrhoea, Nasopharyngitis, Dizziness, Abdominal pain upper, Cough, Retching, Fatigue, Sinusitis, Infection, Rhinitis, Abdominal pain, Dyspnoea, Abdominal discomfort, Drug resistance, Pain, Pain in extremity, Head discomfort, Decreased appetite, Vision blurred, Illness, Weight decreased, Arthralgia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, PANTOPRAZOLE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALPELISIB, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, EXEMESTANE, CLONAZEPAM, CAPECITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, ERGOCALCIFEROL, |
||||
| 177 | 26915768 |
US |
||
Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 178 | 26915774 |
GB |
||
Diplopia, Visual impairment, |
||||
RIVAROXABAN, |
||||
| 179 | 26916160 |
CA |
43 | 2 |
Fibromyalgia, Folliculitis, Gait disturbance, Fatigue, Arthropathy, Autoimmune disorder, Breast cancer stage II, Abdominal discomfort, Hypocholesterolaemia, Retinitis, Visual impairment, Product use issue, Incorrect route of product administration, Medication error, Off label use, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, OXYCODONE, OXYCODONE, OXYCODONE, CELECOXIB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 180 | 26916289 |
US |
||
Visual impairment, |
||||
TIRZEPATIDE, |
||||
| 181 | 26916479 |
US |
1 | |
Visual impairment, |
||||
DABRAFENIB, TRAMETINIB, |
||||
| 182 | 26916540 |
CA |
36 | 1 |
Involuntary medical treatment, Apnoea, Torticollis, Thinking abnormal, Haematoma, Abnormal behaviour, Psychotic disorder, Aphasia, Weight decreased, Frequent bowel movements, Stress, Photosensitivity reaction, Photopsia, Balance disorder, Aspiration, Neuropathy peripheral, Visual impairment, Acalculia, Vision blurred, Tinnitus, Syncope, Agitation, Oedema, Loss of consciousness, Insomnia, Dizziness, Nausea, Hypotension, |
||||
RISPERIDONE, RISPERIDONE, HALOPERIDOL, HALOPERIDOL LACTATE, |
||||
| 183 | 26916677 |
US |
73 | 2 |
Fatigue, Visual impairment, |
||||
DULAGLUTIDE, |
||||
| 184 | 26916835 |
44 | 2 | |
Asthenia, Bursitis, Confusional state, Deep vein thrombosis, Dizziness, General physical health deterioration, Hypersensitivity, Insomnia, Lip dry, Pain in extremity, Rheumatoid arthritis, Swelling, Synovitis, Systemic lupus erythematosus, Tachycardia, Treatment failure, Upper respiratory tract infection, Visual impairment, Walking aid user, Weight decreased, Weight fluctuation, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, Medication error, Off label use, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, |
||||
| 185 | 26916987 |
US |
61 | 2 |
Cataract operation, Constipation, Visual impairment, Diarrhoea, |
||||
ORAL SEMAGLUTIDE, |
||||
| 186 | 26917356 |
GB |
56 | 2 |
Optic nerve cupping, Intraocular pressure increased, Visual impairment, Vitrectomy, Medical device removal, |
||||
FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE, |
||||
| 187 | 26917403 |
EU |
73 | 2 |
Psoriasis, Visual impairment, Oral candidiasis, Iron deficiency anaemia, Spinal osteoarthritis, |
||||
BIMEKIZUMAB, IXEKIZUMAB, |
||||
| 188 | 26917425 |
US |
2 | |
Muscle spasms, Visual impairment, |
||||
ORFORGLIPRON, |
||||
| 189 | 26917660 |
US |
2 | |
Visual impairment, |
||||
TIRZEPATIDE, |
||||
| 190 | 26917674 |
ZA |
1 | |
Visual impairment, Retinal thickening, |
||||
FARICIMAB, FARICIMAB, FARICIMAB, |
||||
| 191 | 26917984 |
EU |
27 | 2 |
Dizziness, Balance disorder, Disturbance in attention, Visual impairment, Sjogren^s syndrome, Sarcopenia, Gastrointestinal disorder, Hypoaesthesia, Oesophageal disorder, Abdominal pain, Abdominal distension, Coeliac disease, Vision blurred, Visual impairment, Dysphagia, Diarrhoea, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, |
||||
| 192 | 26918213 |
BR |
56 | 2 |
Dysentery, Lung cancer metastatic, Second primary malignancy, Blood glucose abnormal, Paraesthesia, Skin disorder, Feeding disorder, Arthropathy, Skin exfoliation, Liver disorder, Weight increased, Hypotonia, Weight decreased, Diarrhoea, Dry skin, Rash, Diarrhoea, Mucosal dryness, Aphthous ulcer, Pruritus, Blood glucose increased, Mucosal inflammation, Hepatic enzyme abnormal, Malaise, Nutritional condition abnormal, Liver function test abnormal, Skin discolouration, Glossodynia, Gingival erythema, Bradykinesia, Hypotension, Gastrointestinal disorder, Muscle atrophy, Visual impairment, Memory impairment, Anxiety, Abdominal discomfort, Adverse reaction, Hormone level abnormal, Illness, COVID-19, Dysarthria, Dyspnoea, Blood glucose increased, Erythema, Gingival pain, Fatigue, Abdominal pain upper, Myalgia, Arthralgia, Lung disorder, Posture abnormal, |
||||
FULVESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, |
||||
| 193 | 26918267 |
US |
81 | 2 |
Visual impairment, Off label use, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 194 | 26918699 |
US |
1 | |
Visual impairment, |
||||
TIRZEPATIDE, |
||||
| 195 | 26919023 |
US |
72 | 2 |
Visual impairment, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 196 | 26919205 |
US |
78 | 2 |
Visual impairment, Eye irritation, |
||||
ACOLTREMON, HYDROXYCHLOROQUINE, |
||||
| 197 | 26919206 |
US |
76 | 1 |
Visual impairment, Drug ineffective, |
||||
ACOLTREMON, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), ROSUVASTATIN, |
||||
| 198 | 26919344 |
US |
69 | 2 |
Visual impairment, Eye irritation, |
||||
ACOLTREMON, AMLODIPINE, HYDROCHLOROTHIAZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, SPIRONOLACTONE, |
||||
| 199 | 26919362 |
US |
73 | 2 |
Visual impairment, Dry eye, Eye irritation, |
||||
CYCLOSPORINE, ACOLTREMON, |
||||
| 200 | 26919389 |
US |
78 | 2 |
Visual impairment, Vision blurred, Eye pain, Drug ineffective, |
||||
POVIDONE, PROPYLENE GLYCOL EMULSION, PROPYLENE GLYCOL, ACOLTREMON, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, HYDROCHLOROTHIAZIDE, LISINOPRIL, SERTRALINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30